These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15963284)

  • 1. Fluoroquinolone-resistant Escherichia coli carriage in long-term care facility.
    Maslow JN; Lee B; Lautenbach E
    Emerg Infect Dis; 2005 Jun; 11(6):889-94. PubMed ID: 15963284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for the development of gastrointestinal colonization with fluoroquinolone-resistant Escherichia coli in residents of long-term care facilities.
    Han JH; Maslow J; Han X; Xie SX; Tolomeo P; Santana E; Carson L; Lautenbach E
    J Infect Dis; 2014 Feb; 209(3):420-5. PubMed ID: 23986544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geographic distribution of fluoroquinolone-resistant Escherichia coli strains in Asia.
    Uchida Y; Mochimaru T; Morokuma Y; Kiyosuke M; Fujise M; Eto F; Harada Y; Kadowaki M; Shimono N; Kang D
    Int J Antimicrob Agents; 2010 Apr; 35(4):387-91. PubMed ID: 20138480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excess body weight and age associated with the carriage of fluoroquinolone and third-generation cephalosporin resistance genes in commensal Escherichia coli from a cohort of urban Vietnamese children.
    Thi Quynh Nhi L; Thanh Tuyen H; Duc Trung P; Do Hoang Nhu T; Duy PT; Hao CT; Thi Thanh Nhan N; Vi LL; Thi Diem Tuyet H; Thi Thuy Tien T; Van Vinh Chau N; Khanh Lam P; Thwaites G; Baker S
    J Med Microbiol; 2018 Oct; 67(10):1457-1466. PubMed ID: 30113307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the use of urine samples to detect colonization with fluoroquinolone-susceptible and fluoroquinolone-resistant Escherichia coli.
    Lautenbach E; Babson A; Santana E; Tolomeo P; Black N; Smith CA; Maslow J
    Infect Control Hosp Epidemiol; 2009 Apr; 30(4):396-7. PubMed ID: 19245313
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevalence of fluoroquinolone-resistant Escherichia coli O25:H4-ST131 (CTX-M-15-nonproducing) strains isolated in Japan.
    Yokota S; Sato T; Okubo T; Ohkoshi Y; Okabayashi T; Kuwahara O; Tamura Y; Fujii N
    Chemotherapy; 2012; 58(1):52-9. PubMed ID: 22343392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy--should we reassess our practices for antibiotic prophylaxis?
    Steensels D; Slabbaert K; De Wever L; Vermeersch P; Van Poppel H; Verhaegen J
    Clin Microbiol Infect; 2012 Jun; 18(6):575-81. PubMed ID: 21958149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for fecal colonization with multiple distinct strains of Escherichia coli among long-term care facility residents.
    Lautenbach E; Tolomeo P; Black N; Maslow JN
    Infect Control Hosp Epidemiol; 2009 May; 30(5):491-3. PubMed ID: 19292660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and characteristics of Escherichia coli sequence type 131 (ST131) from long-term care facility residents colonized intestinally with fluoroquinolone-resistant Escherichia coli.
    Han JH; Garrigan C; Johnston B; Nachamkin I; Clabots C; Bilker WB; Santana E; Tolomeo P; Maslow J; Myers J; Carson L; Lautenbach E; Johnson JR;
    Diagn Microbiol Infect Dis; 2017 Mar; 87(3):275-280. PubMed ID: 27939288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic susceptibility of intestinal Escherichia coli in men undergoing transrectal prostate biopsies: a prospective, registered, multicentre study.
    Knaapila J; Kallio H; Hakanen AJ; Syvänen K; Ettala O; Kähkönen E; Lamminen T; Seppänen M; Jambor I; Rannikko A; Riikonen J; Munukka E; Eerola E; Gunell M; Boström PJ
    BJU Int; 2018 Aug; 122(2):203-210. PubMed ID: 29533507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoroquinolone resistance in uncomplicated acute pyelonephritis: epidemiology and clinical impact.
    Shin J; Kim J; Wie SH; Cho YK; Lim SK; Shin SY; Yeom JS; Lee JS; Kweon KT; Lee H; Cheong HJ; Park SH; Park DW; Ryu SY; Chung MH; Yoo S; Pai H
    Microb Drug Resist; 2012 Apr; 18(2):169-75. PubMed ID: 22400491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Farm-level risk factors for fluoroquinolone resistance in E. coli and thermophilic Campylobacter spp. on finisher pig farms.
    Taylor NM; Clifton-Hadley FA; Wales AD; Ridley A; Davies RH
    Epidemiol Infect; 2009 Aug; 137(8):1121-34. PubMed ID: 19134238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli.
    Rooney PJ; O'Leary MC; Loughrey AC; McCalmont M; Smyth B; Donaghy P; Badri M; Woodford N; Karisik E; Livermore DM
    J Antimicrob Chemother; 2009 Sep; 64(3):635-41. PubMed ID: 19549667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does mutation in gyrA and/or parC or efflux pump expression play the main role in fluoroquinolone resistance in Escherichia coli urinary tract infections?: A statistical analysis study.
    Shigemura K; Tanaka K; Yamamichi F; Shirakawa T; Miyake H; Fujisawa M
    Int J Antimicrob Agents; 2012 Dec; 40(6):516-20. PubMed ID: 23068598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for ambulatory urinary tract infections caused by high-MIC fluoroquinolone-susceptible Escherichia coli in women: results from a large case-control study.
    Rattanaumpawan P; Nachamkin I; Bilker WB; Roy JA; Metlay JP; Zaoutis TE; Lautenbach E;
    J Antimicrob Chemother; 2015 May; 70(5):1547-51. PubMed ID: 25630645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of cross-resistance to aminoglycosides in fluoroquinolone-resistant Escherichia coli clinical isolates.
    Tsukamoto N; Ohkoshi Y; Okubo T; Sato T; Kuwahara O; Fujii N; Tamura Y; Yokota S
    Chemotherapy; 2013; 59(5):379-84. PubMed ID: 24852043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Carriage of Ciprofloxacin-Resistant Escherichia coli Isolates in High-Risk Nursing Home Residents.
    Ismail MD; Luo T; McNamara S; Lansing B; Koo E; Mody L; Foxman B
    Infect Control Hosp Epidemiol; 2016 Apr; 37(4):440-7. PubMed ID: 26782632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic and genotypic characterization of fecal Escherichia coli isolates with decreased susceptibility to fluoroquinolones: results from a large hospital-based surveillance initiative.
    Lautenbach E; Fishman NO; Metlay JP; Mao X; Bilker WB; Tolomeo P; Nachamkin I
    J Infect Dis; 2006 Jul; 194(1):79-85. PubMed ID: 16741885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A survey of plasmid-mediated fluoroquinolone resistance genes from Escherichia coli isolates and their dissemination in Shandong, China.
    Xia LN; Li L; Wu CM; Liu YQ; Tao XQ; Dai L; Qi YH; Lu LM; Shen JZ
    Foodborne Pathog Dis; 2010 Feb; 7(2):207-15. PubMed ID: 19911944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factor of community-onset spontaneous bacterial peritonitis caused by fluoroquinolone-resistant Escherichia coli in patients with cirrhosis.
    Kim J; Kang CI; Joo EJ; Ha YE; Cho SY; Gwak GY; Chung DR; Peck KR; Song JH
    Liver Int; 2014 May; 34(5):695-9. PubMed ID: 24267669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.